早期动脉样硬化中的炎症和脂质生物标志物:全面分析
Alim Namitokov1,2, Karina Karabakhtsieva2, Olga Malyarevskaya2
1Department of Therapy #1, Kuban State Medical University, Sedina Street 4, 350063 Krasnodar, Russia.
Life (Basel, Switzerland)
|October 26, 2024
概括
系统性炎症和脂质异常预测18-55岁的成年人早期动脉样硬化. 系统性免疫炎症指数 (SIRI) 和血管蛋白类3 (ANGPTL3) 的升高是疾病存在的关键指标.
科学领域:
- 心血管医学 心血管医学
- 生物标志物 生物标志物
- 炎症研究 炎症研究
背景情况:
- 动脉样硬化,标志着动脉脂质的积累和炎症,是主要的心血管疾病风险.
- 在年轻成年人 (18-55岁) 早期检测对于预防不良事件至关重要.
研究的目的:
- 研究18-55岁成年人的炎症指数,脂质生物标志物和动脉样硬化之间的关联.
- 为了确定早期动脉样硬化检测的预测标记.
主要方法:
- 89名参与者的横截面研究 (62名动脉样硬化,27名对照).
- 收集的人口,临床和实验室数据以及计算的炎症指数 (SIRI,SII,AISI,NLR,PLR,MLR).
- 利用统计分析,包括后勤回归,ROC曲线和机器学习分类器.
主要成果:
- 动脉样硬化患者的炎症指数 (SIRI,NLR,MLR,SII) 和脂质异常 (TC,LDL-C,HDL-C) 较高.
- 在动脉样硬化组 (p < 0.001和p < 0.01) 观察到显著升高的Lp (a) 和ANGPTL3水平.
- SIRI和ANGPTL3成为重要的预测因素,预测模型达到77%的准确性和93%的灵敏度.
结论:
- 系统性炎症和脂质失调在年轻成年人早期动脉样硬化中至关重要.
- 升高的SIRI和ANGPTL3是动脉样硬化的强有力的预测因素.
- 整合炎症标志物和脂质可以改善风险分层,并支持个性化医疗.
相关概念视频
01:38Inflammation
52.9K
Overview
52.9K
01:30Atherosclerosis I: Introduction
1
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1
01:26Atherosclerosis III: Management
1
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
1
01:27Atherosclerosis II: Clinical manifestations and prevention
1
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
1
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
01:30Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3